ACSF2_DANRE
ID ACSF2_DANRE Reviewed; 606 AA.
AC Q0P4F7;
DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT 19-SEP-2006, sequence version 1.
DT 03-AUG-2022, entry version 68.
DE RecName: Full=Medium-chain acyl-CoA ligase ACSF2, mitochondrial {ECO:0000250|UniProtKB:Q96CM8};
DE EC=6.2.1.2 {ECO:0000250|UniProtKB:Q96CM8};
DE Flags: Precursor;
GN Name=acsf2 {ECO:0000250|UniProtKB:Q96CM8}; ORFNames=zgc:152887;
OS Danio rerio (Zebrafish) (Brachydanio rerio).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC Danionidae; Danioninae; Danio.
OX NCBI_TaxID=7955;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC STRAIN=AB;
RG NIH - Zebrafish Gene Collection (ZGC) project;
RL Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Acyl-CoA synthases catalyze the initial reaction in fatty
CC acid metabolism, by forming a thioester with CoA. Has some preference
CC toward medium-chain substrates. Plays a role in adipocyte
CC differentiation. {ECO:0000250|UniProtKB:Q96CM8}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a medium chain fatty acid + ATP + CoA = a medium-chain fatty
CC acyl-CoA + AMP + diphosphate; Xref=Rhea:RHEA:48340,
CC ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287,
CC ChEBI:CHEBI:59558, ChEBI:CHEBI:90546, ChEBI:CHEBI:456215; EC=6.2.1.2;
CC Evidence={ECO:0000250|UniProtKB:Q96CM8};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + CoA + octanoate = AMP + diphosphate + octanoyl-CoA;
CC Xref=Rhea:RHEA:33631, ChEBI:CHEBI:25646, ChEBI:CHEBI:30616,
CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57386,
CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q96CM8};
CC -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.
CC -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC122098; AAI22099.1; -; mRNA.
DR AlphaFoldDB; Q0P4F7; -.
DR SMR; Q0P4F7; -.
DR STRING; 7955.ENSDARP00000081474; -.
DR PaxDb; Q0P4F7; -.
DR ZFIN; ZDB-GENE-060825-7; acsf2.
DR eggNOG; KOG1177; Eukaryota.
DR InParanoid; Q0P4F7; -.
DR PhylomeDB; Q0P4F7; -.
DR Reactome; R-DRE-77289; Mitochondrial Fatty Acid Beta-Oxidation.
DR PRO; PR:Q0P4F7; -.
DR Proteomes; UP000000437; Genome assembly.
DR Proteomes; UP000814640; Unplaced.
DR GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0047760; F:butyrate-CoA ligase activity; IEA:UniProtKB-EC.
DR GO; GO:0031956; F:medium-chain fatty acid-CoA ligase activity; ISS:UniProtKB.
DR GO; GO:0006631; P:fatty acid metabolic process; IBA:GO_Central.
DR Gene3D; 3.30.300.30; -; 1.
DR Gene3D; 3.40.50.12780; -; 1.
DR InterPro; IPR025110; AMP-bd_C.
DR InterPro; IPR045851; AMP-bd_C_sf.
DR InterPro; IPR020845; AMP-binding_CS.
DR InterPro; IPR000873; AMP-dep_Synth/Lig.
DR InterPro; IPR042099; ANL_N_sf.
DR Pfam; PF00501; AMP-binding; 1.
DR Pfam; PF13193; AMP-binding_C; 1.
DR PROSITE; PS00455; AMP_BINDING; 1.
PE 2: Evidence at transcript level;
KW ATP-binding; Fatty acid metabolism; Ligase; Lipid metabolism;
KW Mitochondrion; Nucleotide-binding; Reference proteome; Transit peptide.
FT TRANSIT 1..13
FT /note="Mitochondrion"
FT /evidence="ECO:0000255"
FT CHAIN 14..606
FT /note="Medium-chain acyl-CoA ligase ACSF2, mitochondrial"
FT /id="PRO_0000315798"
FT BINDING 256..264
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250"
FT BINDING 484
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250"
FT BINDING 499
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250"
FT BINDING 590
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000250"
SQ SEQUENCE 606 AA; 67514 MW; D2FD627E986DF056 CRC64;
MSSKILLTNL RTSASFCKTL KFPQRPRTPF IASQQSCAIH VDNPPSIPTL TTSYVHGLSS
HPLQSSTVDQ CLQATVERYP DREAMVFVQD GIRKTFAEFY QDVEKAAAGL LAAGLKRGDR
LGMWGPNIYE WVLMQFATAK AGIILVAVNP AYQLQEVEFA LRKVQCNAVV CPTKFKSQHY
CDMLKQLCPE METASPGGIK SSRLPDLHTV IVTDSQQPGS FLLKDLMQAG SSQHYQQLQD
LQKKLVCDDP INIQFTSGTT GKPKGATLSH HNIVNNAYFT GMRIGYNWRK NVRICLPVPL
YHCFGSVGGG VIMALYGTTV IFPSTGYDGR ANLRAIEKEK CTFVYGTPTM YIDMLGQPDL
AKFDLSSVRG GIAAGSPCPP EVMRKILNVM GIKEMVIGYG TTENSPVTFC GFPVDSAERK
IVTVGCISPH TEAKVVDPTT GEIVPLGAQG ELMIRGYCVM LEYWQDEEKT RECITKDRWY
KTGDIASLDQ FAYCKIEGRI KDLIIRGGEN IYPAEIEQFL HTHPKILEAQ VVGVKDERMG
EEVCACIRLK EGQECTVEEI KAYCKGKIAH YKVPRYILFV QDYPLTITGK IQKHKLRERT
EKQLGL